BlackRock »

Coeptis Therapeutics Hldgs I shares owned by BlackRock

Quarter-by-quarter ownership of Coeptis Therapeutics Hldgs I (COEP) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Coeptis Therapeutics Hldgs I

Tip: Access up to 7 years of quarterly data

All positions including Coeptis Therapeutics Hldgs I held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coeptis Therapeutics Hldgs I by BlackRock

Quarter filed Position value Share count Share price at filing
2025-12-31 $193k 14k 14.25

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)

View all positions for BlackRock

Top funds holding Coeptis Therapeutics Hldgs I

Vanguard Group
Geode Capital Management
State Street Corporation
Marshall Wace
BlackRock
Northern Trust
Steward Partners Investment Advisory
Pnc Financial Services
UBS Group
Advisor Group Holdings
SageView Advisory Group
Barclays

View all funds holding Coeptis Therapeutics Hldgs I